Guide to the primary therapy of WM. HV indicates hyperviscosity; cp, centipoise; BDR, bortezomib, dexamethasone, rituximab; CPR, cyclophosphamide, prednisone, rituximab; RCD, rituximab, cyclophosphamide, dexamethasone; VR, bortezomib, rituximab; FR, fludara...

Steven P. Treon Blood 2009;114:2375-2385

©2009 by American Society of Hematology